BioSpace News Archive

XVIVO Perfusion AB’s board of directors announces that CEO Dag Andersson has suddenly passed away.

Element Biosciences, Inc. announced updated specifications to their AVITI System, increasing the platform’s specifications from 800 million reads per flow cell to 1.0 billion reads per flow cell*, further reducing the price per Gigabase.

Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the third quarter of 2022 before the market opens on Thursday, Oct. 27, 2022.

Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage biopharmaceutical company, announced today that enrollment for the Phase I clinical study of BAT2022 has been completed, showing that BAT2022 is well-tolerated and there were no DLT observed up to the dose of 1500mg, the highest dose tested. BAT2022 is a broadly potent neutralizing bi-specific antibody against SARS-CoV-2.

Tavros Therapeutics today announced the completion of a $7.5 million oversubscribed Seed II financing.

Elucidata announced that it has raised $16 million in a Series A fundraising today.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) today announced that Vertex has concluded discussions with the U.S. Food and Drug Administration (FDA), and the FDA granted exagamglogene autotemcel (exa-cel) a rolling review for the potential treatment of sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT).

Oyster Point Pharma, Inc. announced it will present new scientific analyses at World Cornea Congress VIII, which is taking place in Chicago, Illinois from September 28-29, 2022.

Celularity Inc. today announced that Robert Hariri, M.D., Ph.D., Founder, Chairman and Chief Executive Officer of Celularity, will present at the Jefferies Cell and Genetic Medicine Summit on Friday, September 30, 2022 at 11 a.m. ET.

Nemaura Medical, Inc. announces that it has entered into a preliminary agreement with EVERSANA®, a pioneer of next-generation commercial services to the global life sciences industry.